CRT DEVICES

CONNECTED THROUGH LIFE

Healthcare Professionals Cardiac Rhythm Management Cardiac Rhythm Management Products CRT devices

TALENTIA 4LV SONR®

Safeguarding your future

Being the longest-lasting 1.5 and 3T full body MRI-conditional CRT-D4, and featuring BlueTooth Low Energya (BLE) connectivity Talentia™ 4LV SonR® defibrillators represents MicroPort® CRM's latest development in the field of cardiac care and heart failure management. Thanks to the SonR® technology, the world's only automatic CRT algorithm that is based on cardiac contractility, Talentia 4LV SonR® can provide continuous and advanced CRT optimization, improving the clinical outcomes.1,2

AUTOMRI™ adaptive intelligence allows Talentia SonR® to automatically adapt to the MRI scanning environment, enabling essential therapies to provide a safe MRI pathway for your patients.6

Features

  • BlueTooth Low Energy (BLE) connectivity – offers a high-quality connection for a seamless experience.
  • Outstanding longevity4 – Protects patients from consequences of avoidable device replacement.5
  • AUTOMRI™ – Provides the most appropriate therapy for as long as possible.6
  • SonR® – Reduces the risk of heart failure hospitalization by 35% thanks to a CRT optimization automatically tailored to each patient’s need.9-10
  • PARAD+™ including the Long Cycle Search – Achieves the lowest rate of inappropriate shocks ever reported in the literature.2,3
  • Lead Parameter Evaluation (LPE) – Enhances patient’s protection through earlier lead failure detection and alert.
  • BTO™ – Brady Tachy Overlap. Supports patient exercise and detects slow ventricular tachycardia simultaneously.
  • WARAD™ – Window of Atrial Rate Acceleration Detection. Accurately detects AF even in case of undersensing using a dynamic atrial window.3
  • Multipoint Pacing™ – Captures a broader area of the left ventricle.4
  • Remote monitoring with SmartView™ Connect – Offers advanced patient monitoring and follow-up, providing timely alerts and detailed reports.

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.

Click here to know more
CRT devices T 4 LV 1

ENERGYA 4LV™

Designed with you in mind

Energya™4LV , the latest Microport® CRM CRT-D, is designed to provide high-standard therapies while making patient management seamless and effortless. Thanks to smart and advanced solutions like AUTOMRI™ and featuring BlueTooth Low Energya (BLE) connectivity, this 1.5 and 3T full body MRI-conditional CRT-D4 device can save valuable time for both healthcare professionals and patients.

Moreover, being the longest-lasting CRT-D device and featuring specific solutions to enhance the specificity of the therapy, Energya 4LV™, guarantees continuous and advanced patient care still making implantation and follow-ups and effortless experience.

Features

  • BlueTooth Low Energy (BLE) connectivity – offers a high-quality connection for a seamless experience;
  • Outstanding longevity4 – Frees you from early replacements and associated complications.5
  • AutoMRI™ – Makes MRI pathway safe for your patients and easy for you.6
  • PARAD+™ including the Long Cycle Search – Achieves the lowest rate of inappropriate shocks ever reported in the literature.2,3
  • Lead Parameter Evaluation (LPE) – Enhances patient’s protection through earlier lead failure detection and alert.
  • BTO™ – Brady Tachy Overlap. Avoids time-wasting parameter conflicts, making programming easier and faster.
  • Remote monitoring with SmartView™ Connect – Provides streamlined access to patient information, helping to prevent frequent or unnecessary hospital visits.

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.

Click here to know more
CRT devices E 4 LV 2

Gali 4LV SonR®

Enhanced intelligence for optimal outcomes

Besides being the longest-lasting 1.5 and 3T full body MRI-conditional CRT-D1,2, Gali 4LV SonR® features the world's only automatic CRT algorithm that is based on cardiac contractility, enabling it to improve clinical outcomes providing continuous and advanced patient care.3,4

AUTOMRI™ adaptive intelligence allows Gali SonR® to automatically adapt to the MRI scanning environment, enabling essential therapies to provide a safe MRI pathway for your patients.2

Features 
 

  • Outstanding longevity1 – Protects your patients from early replacements and associated complications.5
  • AUTOMRI™ – Makes MRI pathway safe for your patients and easy for you.2
  • SonR® – Provides effective, individualized, automatic, and frequent CRT optimization at rest and exercise.4
  • PARAD+™ including the Long Cycle Search – Achieves the lowest rate of inappropriate shocks ever reported in literature.6
  • BTO™ – Brady Tachy Overlap. Supports patient exercise and detects slow ventricular tachycardia simultaneously.
  • WARAD™ – Window of Atrial Rate Acceleration Detection. Accurately detects AF even in case of undersensing using a dynamic atrial window.7
     
  • Multipoint Pacing™ – Captures a broader area of the left ventricle.8
  • Remote monitoring with SmartView™ monitor – Offers advanced patient monitoring and follow-up, providing timely alerts and detailed reports.

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.
 

Click here to know more Watch the video
CRT devices GALI 4 LV SONR CRT D 2844 front 05x 1 3

Gali 4LV™

Adaptive technology for streamlined workflow and advanced patient care

Besides being the longest-lasting 1.5 and 3T full body MRI-conditional CRT-D1,2, Gali 4LV™ guarantees continuous, advanced patient care while device dimensions, design and preset programming make implantation, and follow-up effortless.

AUTOMRI™ adaptive intelligence allows Gali™ to automatically adapt to the MRI scanning environment, ensuring that essential therapies are enabled and providing a seamless MRI pathway for your patients.2

Features

  • Outstanding longevity1 – Frees you from early replacements and associated complications.3
  • AUTOMRI™ – Makes MRI pathway safe for your patients and easy for you.2
  • PARAD+™ including the Long Cycle Search – Achieves the lowest rate of inappropriate shocks ever reported in literature.4
  • BTO™ – Brady Tachy Overlap. Supports patient exercise and detects slow ventricular tachycardia simultaneously.
  • Multipoint Pacing™ – Captures a broader area of the left ventricle.5
  • Remote monitoring with SmartView™ monitor – Offers efficient access to patient data that keeps your patients out of hospital.

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.


Click here to know more
CRT devices GALI 4 LV CRT D 2744 front 05x 4

Platinium 4LV SonR®

Gives every patient a chance to become responder

Platinium 4LV SonR® gives every patient a chance to become a responder thanks to multiple therapeutic options and features the world’s greatest projected longevity.1

Features

  • SonR® – World's only contractility sensor for automatic CRT optimization. 35% risk reduction in heart failure hospitalization.2,3
  • PARAD+™ – World’s first dual-chamber arrhythmia discrimination algorithm. Best-in-class 99% overall specificity.4
  • BTO™ – Brady Tachy Overlap. Ensures resynchronization whatever the patients condition.
  • 14 LV vectors – More LV vectors for flexible pacing.
  • Multipoint Pacing™ – Captures a broader area of the left ventricle.5

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.

Click here to know more
CRT devices PLATINIUM 4 LV SONR 1844 Micro Port front 5

PLATINIUM 4LV™

Featuring the world’s greatest projected longevity1

Platinium 4LV™ is small in design with no compromize on longevity: it features the world's greatest projected longevity.1

Features

  • PARAD+™ – World’s first dual-chamber arrhythmia discrimination algorithm. Best-in-class 99% overall specificity.2
  • BTO™ – Brady Tachy Overlap. Ensures resynchronization whatever the patients condition.
  • 14 LV vectors – More LV vectors for flexible pacing.
  • Multipoint Pacing™ – Captures a broader area of the left ventricle.3

Multipoint Pacing™ is not available for sale or distribution in the USA.

Click here to know more
CRT devices PLATINIUM 4 LV CRT D 1744 Micro Port front 6

REPLY™

Our groundbreaking research has allowed us to develop the world’s smallest Cardiac Resynchronization Therapy pacemaker.1

Features

  • Sleep Apnea Monitoring™: Early detection, lifetime monitoring. SAM allows you to screen patients for severe sleep apnea as well as monitor the evolution of the disease.
  • Dual Sensors™: Need for accurate Rate Response in CRT. Exercise is proven to have positive effects on mortality, morbidity and quality of life for CRT patients.2,3,4

This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.
 

CRT devices Reply CRT P Micro Port 2018 7

Learn more about MicroPort CRT Longevity
CRT devices Adobe Stock 329275104 8
Parad

PARAD+™

is the world’s first discrimination algorithm protecting patients from inappropriate shocks for over 20 years.

Discover this therapy
Son R Logo transparent

SonR®

allows for automatic CRT optimization based on a cardiac contractility sensor.

Discover this therapy
BTO

Brady Tachy Overlap (BTO™)

allows the patient to benefit from ventricular pacing during exercise while maintaining slow VT detection and therapy.

Discover this therapy
Multipoint

Multipoint pacing™

allows to pace the LV simultaneously at two different sites as a solution to optimize CRT for non-responder patients.

Discover this therapy

TECH CORNER

PICTO Paper article

Window of Atrial Rate Acceleration Detection (WARAD)

The WARAD is designed to monitor the atrial activity in order to discriminate pathological atrial waves (Atrial Fibrillation, Atrial Flutter, Atrial Tachycardias) from sinus P waves. This atrial discriminator uses atrial prematurity to trigger mode switching. Refer also to the Fallback Mode Switch Tech Corner article for more details on the Fallback Mode Switch algorithm.

Click here for full article
PICTO Paper article

Fallback Mode Switch

The FMS function is designed to diagnose atrial arrhythmias and manage their occurrence using the WARAD (Window of Atrial Rate Acceleration Detection): in the event of atrial arrhythmia, FMS switches from DDD®, SafeR® or Dplus® pacing mode to an inhibited dual- chamber pacing mode DDI® to avoid prolonged ventricular pacing at a high rate for the entire duration of the sustained atrial arrhythmia.

Click here for full article
PICTO Paper article

Anti-PMT (Pacemaker Mediated Tachycardia) algorithm

The Anti-PMT algorithm is intended to protect the patient from Pacemaker-Mediated Tachycardia (PMT) without reducing the atrial sensing capability of the device.

Click here for full article
PICTO Paper article

SonR® CRT Optimization

SonR® is a specific sensor, located at the tip of the atrial lead (SonRtip), that picks up micro-accelerations of the heart walls to derive information pertaining to cardiac contractility. The SonR® algorithm automatically determines the optimal VV and AV delays during rest and exercise by using the endocardial acceleration signal measured by the SonRtip lead. In addition, the SonR® signal is recorded during tachyarrhythmia episodes to show acute variations of cardiac contractility.

Click here for full article
PICTO Paper article

Tachyarrhythmia Suspicion and Detection

The challenge for any device is to determine whether an elevated ventricular rate corresponds to a true ventricular tachyarrhythmia requiring device therapy or not (in the event that the elevated rate is not of ventricular origin). Throughout this article we will explore how MicroPort detects arrhythmias in dual and triple chamber ICDs. Please refer also to the PARAD/PARAD+ Tech Corner article to learn how PARAD+ operates in the VT/Slow VT zones to discriminate VTs from other rhythms.

Click here for full article
PICTO Paper article

PARAD/PARAD+: Arrhythmia Detection

The proper detection of VT requires a specific algorithm (arrhythmia discrimination) to discriminate ventricular tachycardia from Supraventricular tachycardia (SVT) or sinus tachycardia (ST). The MicroPort core algorithms used for rhythms within the VT zone are called PARAD and PARAD+.

Click here for full article
PICTO Paper article

ATP in the Fast VT zone

The fast VT zone offers the possibility to attempt painless ATP to terminate fast ventricular arrhythmias in a defined portion of the VF zone.

Click here for full article
PICTO Paper article

Automatic Ventricular Sensitivity Control (ASC)

The ASC is an essential of sensing used in MicroPort Implantable Cardiac Defibrillators to ensure appropriate sensing for all ventricular rhythms at all rates. It dynamically adapts the sensitivity to the changing endocardial signal in an attempt to detect each and every R wave.

Click here for full article
PICTO Paper article

Brady Tachy Overlap (BTO)

Brady-Tachy Overlap (BTO) is a function which starts as soon as the pacing zone and the Slow VT detection zone overlap by programming the maximum pacing rate faster than the slow VT detection rate. It allows the patient to benefit from biventricular (CRT-D) and ventricular (ICD) pacing during exercise while maintaining slow VT detection and therapy if programmed.

Click here for full article
PICTO Paper article

Alerts – System, Lead, Tachy Therapy and Clinical Alerts

In patients’ daily life, some clinical or device-related events need to be communicated to the physician or someone in the hospital or clinic’s team. Alerts are ALWAYS programmed through the programmer. They are triggered automatically by the device when the selected event occurs.

Click here for full article

MICROPORT® Manuals

http://www.microportmanuals.com/

Refer to user’s manual supplied with the device for complete instructions for use, intended use and relevant warnings, precautions, side effects, and contraindications.

 

Availability of products and functions vary by country. Please check with your representative for further information.

TALENTIA 4LV SONR® REFERENCES

  1. Hofer D, Steffel J, Hürlimann D et al. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice—an underestimated complication?. J Interv Card Electrophysiol 50, 219–226 (2017).
  2. Ruiz-Granell R, Dovellini EV, Dompnier A, Khalighi K, García-Campo E, Olivier A, Barcelo A, Ritter P. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435
  3. Wolfgang Dichtl, et al. Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study, EP Europace, Volume 25, Issue 9, September 2023, euad186
  4. Competition comparison made as of March 2023, refer to manufacturers manuals and Boston Scientific longevity calculator available online
  5. Borleffs CJ, Thijssen J, de Bie MK, et al. Recurrent implantable cardioverter defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010 Aug;33(8):1013-1019.
  6. MicroPort CRM MRI Solutions Manuals available online at microportmanuals.com
  7. Kolb et al. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. JACC Heart Fail. 2014;2(6):611-619.
  8. Bonnet JL, Brusseau E, Limousin M, et al. Mode switch despite undersensing of atrial fibrillation in DDD pacing. Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1724-8.
  9. Brugada J, Delnoy PP, Brachmann J, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 7;38(10):730-738
  10. Lunati M, Magenta G, Cattafi G, et al. Clinical Relevance Of Systematic CRT Device Optimization. J Atr Fibrillation. 2014 Aug 31;7(2):1077.
  11. Bonnet JL, Brusseau E, Limousin M, et al. Mode switch despite undersensing of atrial fibrillation in DDD pacing. Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1724-8.
  12. Menardi E, Ballari GP, Goletto C, et al. Characterization ventricular activation pattern and hemodynamics during multipoint ventricular pacing. Heart Rhythm. Aug;12(8):1762-9.

ENERGYA 4LV™ REFERENCES

  1. Hofer D, Steffel J, Hürlimann D et al. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice—an underestimated complication?. J Interv Card Electrophysiol 50, 219–226 (2017).
  2. Ruiz-Granell R, Dovellini EV, Dompnier A, Khalighi K, García-Campo E, Olivier A, Barcelo A, Ritter P. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435
  3. Wolfgang Dichtl, et al. Low rates of inappropriate shocks in contemporary real-world implantable cardioverter defibrillator patients: the CARAT observational study, EP Europace, Volume 25, Issue 9, September 2023, euad186
  4. Competition comparison made as of March 2023, refer to manufacturers manuals and Boston Scientific longevity calculator available online
  5. Borleffs CJ, Thijssen J, de Bie MK, et al. Recurrent implantable cardioverter defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010 Aug;33(8):1013-1019.
  6. MicroPort CRM MRI Solutions Manuals available online at microportmanuals.com

GALI 4LV SONR® REFERENCES
 

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  2. MicroPort CRM MRI Solutions Manuals available online at microportmanuals.com.
  3. Lunati M, Magenta G, Cattafi G, et al. Clinical Relevance Of Systematic CRT Device Optimization. J Atr Fibrillation. 2014 Aug 31;7(2):1077.
  4. Brugada J, Delnoy PP, Brachmann J, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 7;38(10):730-738.
  5. Borleffs CJ, Thijssen J, de Bie MK, et al. Recurrent implantable cardioverter defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010
    Aug;33(8):1013-1019.
  6. Ruiz-Granell R, Dovellini EV, Dompnier A, et al. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435.
  7. Bonnet JL, Brusseau E, Limousin M, et al. Mode switch despite undersensing of atrial fibrillation in DDD pacing. Pacing Clin Electrophysiol. 1996 Nov;19(11 Pt 2):1724-8.
  8. Menardi E, Ballari GP, Goletto C, et al. Characterization ventricular activation pattern and hemodynamics during multipoint ventricular pacing. Heart Rhythm. Aug;12(8):1762-9.

GALI 4LV™ REFERENCES
 

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  2. MicroPort CRM MRI Solutions Manuals available online at microportmanuals.com.
  3. Borleffs CJ, Thijssen J, de Bie MK, et al. Recurrent implantable cardioverter defibrillator replacement is associated with an increasing risk of pocket-related complications. Pacing Clin Electrophysiol. 2010
    Aug;33(8):1013-1019.
  4. Ruiz-Granell R, Dovellini EV, Dompnier A, et al. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435.
  5. Menardi E, Ballari GP, Goletto C, et al. Characterization ventricular activation pattern and hemodynamics during multipoint ventricular pacing. Heart Rhythm. Aug;12(8):1762-9.

PLATINIUM 4LV SONR® REFERENCES

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  2. Lunati M, Magenta G, Cattafi G, et al. Clinical Relevance Of Systematic CRT Device Optimization. J Atr Fibrillation. 2014 Aug 31;7(2):1077.
  3. Brugada J, Delnoy PP, Brachmann J, et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 7;38(10):730-738.
  4. Hintringer F, Deibl M, Berger T, et al. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004 Jul;27(7):976-982.
  5. Menardi E, Ballari GP, Goletto C, et al. Characterization ventricular activation pattern and hemodynamics during multipoint ventricular pacing. Heart Rhythm. Aug;12(8):1762-9.

PLATINIUM 4LV™ REFERENCES

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
  2. Hintringer F, Deibl M, Berger T, et al. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004 Jul;27(7):976-982.
  3. Menardi E, Ballari GP, Goletto C, et al. Characterization ventricular activation pattern and hemodynamics during multipoint ventricular pacing. Heart Rhythm. Aug;12(8):1762-9.

Last Updated March 2022